USE OF IMMUNE CELL-SPECIFIC GENE EXPRESSION FOR PROGNOSIS OF PROSTATE CANCER AND PREDICTION OF RESPONSIVENESS TO RADIATION THERAPY

摘要

Methods, systems, and kits for the diagnosis, prognosis and the determinationof cancer progression of prostate cancer ina subject are disclosed. In particular, the disclosure relates to the use ofimmune cell-specific gene expression in determining prognosisand identifying individuals in need of treatment for prostate cancer who willbe responsive to radiation therapy.